PrognomiQ

PrognomiQ Is Enabling Early Disease Detection And Treatment

Who is PrognomiQ?

PrognomiQ leverages the latest advances in proteomics to generate direct information of a person’s biological state, including state of disease. We are passionate about transforming healthcare by enabling the early detection and treatment of cancer and other complex diseases. Proteomics is the large-scale study of protein molecules to understand their roles in biology. The resulting multi-omics data sets provide unparalleled levels of biological insights, including on the mechanisms of the most complex diseases. We believe that early detection and treatment of complex diseases can only be unlocked through the insights provided by high-quality multi-omics data. This powerful multi-omics platform is the engine to develop transformative healthcare products that could impact millions of lives. Philip Ma is Chief Executive Officer, Founder and Board member for PrognomiQ. Chinmay Belthangady is the VP, Data Science at PrognomiQ.

This company is:

Manufacturer

United States

11-50 Employees

Founding year: 2020

Keywords

Medical Device

Biotechnology

Biopharma

Health Care

Industries

Biotechnology

Contact of PrognomiQ

City: -

State: California

Country: United States

Frequently asked questions (FAQ) about PrognomiQ

Where is PrognomiQ located?

The company PrognomiQ is located in California, United States. It's worth noting that the company may has more corporate locations

How many employees does PrognomiQ approximately have?

As of the latest available information PrognomiQ has around 11-50 employees worldwide.

When was PrognomiQ founded?

PrognomiQ was founded in 2020

In which industries does PrognomiQ mainly work?

The company PrognomiQ has it's main focus in the industries of Biotechnology

What is the current company status of PrognomiQ?

Based on the founding year and the amount of employees the company PrognomiQ seems to be a Startup at the current state. Note that over time that status can change